Abstract:<section class="article-section article-section__abstract" lang="en" data-lang="en" id="section-1-en"> <h3 class="article-section__header main main">Abstract</h3> <div class="article-section__content en main"> <p>Hidradenitis suppurativa (HS)/acne inversa is a debilitating chronic disease that remains poorly understood and difficult to manage. Clinical practice is variable and there is a need for international, evidence‐based and easily applicable consensus on HS management. We report here the findings of a systematic literature review, which were subsequently used as a basis for the development of international consensus recommendations for the management of patients with HS.</p> <p>A systematic literature review was performed for each of nine clinical questions in HS (defined by an expert steering committee), covering comorbidity assessment, therapy (medical, surgical and combinations), and response to treatment. Included articles underwent data extraction and were graded according to the Oxford Centre for Evidence‐based Medicine criteria. Evidence‐based recommendations were then drafted, refined, and voted upon, using a modified Delphi process.</p> <p>Overall, 5,310 articles were screened, 171 articles analyzed, and 65 used to derive recommendations. These articles included six randomized controlled trials plus cohort studies and case series. The highest level of evidence concerned dosing recommendations for topical clindamycin in mild disease (with systemic tetracyclines for more frequent/widespread lesions) and biologic therapy (especially adalimumab) as second‐line agents (following conventional therapy failure). Good‐quality evidence was available for the hidradenitis suppurativa clinical response (HiSCR) as a dichotomous outcome measure in inflammatory areas under treatment. Lower‐level evidence supported recommendations for topical triclosan and oral zinc in mild‐to‐moderate HS, systemic clindamycin and rifampicin in moderate HS and intravenous ertapenem in selected patients with more severe disease. Intralesional or systemic steroids may also be considered. Local surgical excision is suggested for mild‐to‐moderate HS, with wide excision for more extensive disease.</p> <p>Despite a paucity of good quality data on management decisions in HS, this systematic review has enabled the development of robust and easily applicable clinical recommendations for international physicians based on graded evidence.</p> <p>This article is protected by copyright. All rights reserved.</p>

Hidradenitis suppurativa: a new therapeutic approach for an old disease

Hidradenitis suppurativa: a review of current treatment options

Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape

Hidradenitis Suppurativa: A Literature Review Comparing Current Therapeutic Modalities

Rethinking Hidradenitis Suppurativa Management: Insights into Bacterial Interactions and Treatment Evolution

Essentials of hidradenitis suppurativa: a comprehensive review of diagnostic and treatment perspectives

Hidradenitis Suppurativa: Molecular Etiology, Pathophysiology, and Management—A Systematic Review

The most recent advances in understanding and managing hidradenitis suppurativa

Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes-A Review of the Literature

Interleukin-17 Inhibitors in the Treatment of Hidradenitis Suppurativa

Hidradenitis Suppurativa: New Targets and Emerging Treatments

Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients

Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model

Hidradenitis Suppurativa: A Review of the Biologic and Small Molecule Immunomodulatory Treatments

Hidradenitis Suppurativa: An Understanding of Genetic Factors and Treatment

The Efficacy and Safety of Biosimilars in Hidradenitis Suppurativa: A Comprehensive Review

Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review

Cytokine-Mediated Molecular Pathophysiology of Hidradenitis Suppurativa: A Narrative Review

Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling

Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group

Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options